Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (137)
- Compliance and enforcement (35)
- Import and export (35)
- Shortages and supply disruptions (17)
- Sunscreens (10)
- Advertising (7)
- COVID-19 (5)
- Labelling and packaging (5)
- Weight loss products (5)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1309 result(s) found, displaying 1251 to 1275
-
Market actionsThe product is being recalled due to possible bacterial contamination.
-
Market actionsIf consumers followed the directions on the label it would lead to the ingestion of 90 milligrams of zinc, an amount which should only be used under medical supervision.
-
Market actionsBrauer Baby and Child Care Calm, 100 ml bottle oral liquid
-
Market actionsRecall of Ventolin inhaler in 2003.
-
-
Market actionsBleph-10 (sulfacetamide sodium 10%) 15 mL eye drops
-
Market actionsThe level of folic acid is substantially lower than the 400mcg stated on the label.
-
Market actionsMYCOSPOR Bifonazole cream, CANESTEN Bifonazole Once Daily Anti-Fungal Body Cream
-
-
Market actionsBenadryl for the Family Dry Cough and Nasal Congestion Liquid
-
Safety alertsWe are advising that products containing Greater Celandine (Chelidonium majus) may cause liver problems. Use under healthcare supervision and consult your doctor if you have concerns.
-
Market actionsRecall letters being dispatched
-
-
Market actionsIn 2003, Pan Pharmaceuticals Limited products were recalled.
-
Market actionsIn 2003, Pan Pharmaceutical Limited products were recalled.
-
Market actionsThe plastic neck insert, a component of the "easy dose" syringe system in the product can be dislodged from the neck of the bottle and remain on the syringe. This component, then loosely attached to the syringe could be dislodged, posing a choking hazard.
-
Market actionsList of Pan Pharmaceuticals products.
-
Market actionsFailure to comply with the mandatory absorbency requirements - AS/NZS 2869:1988 Tampons - menstrual.
-
Market actionsRecall due to failure to comply with the mandatory absorbency requirements of AS/NZS 2869:1988 Tampons - menstrual.
-
Safety alertsFact sheet to inform consumers about the safe use of paracetamol
-
Safety alertsThis fact sheet has been prepared by the Therapeutic Goods Administration to inform health practitioners about the safe use of paracetamol.
-
Market actionsRecall due to failure to comply with the requirements of TGO61 Contraceptive Rubber condoms.
-
Market actionsProduct illegally supplied.
-
Market actionsThe products have failed to comply with the relevant mandatory requirement for absorbency (AS/NZS 2869:1998 Tampons - Menstrual).
-
Market actionsIn 2003, the TGA recalled Pan Pharmaceuticals’ products due to serious safety and manufacturing issues.